Asher Biotherapeutics, a leader in developing targeted immunotherapies, has secured $55 million in Series C funding led by RA...

Volastra Therapeutics has advanced its clinical-stage KIF18A inhibitor, sovilnesib, into Phase Ib clinical trials. The trials will evaluate the...

SpikImm, a biotech company established in 2021, has entered an exclusive agreement with SATT Conectus for the development of...

In silico methodologies have transformed the landscape of drug development, providing a virtual platform to predict and optimize drug...

At the recent Duke-Margolis Institute for Health Policy conference, regulatory experts worldwide gathered to discuss advancements and collaborative strategies...

Marinus Pharmaceuticals recently announced the continuation of its Phase 3 RAISE trial for intravenous (IV) ganaxolone in treating refractory...

Innate Pharma has announced the initiation of the Phase 2 dose expansion portion of a clinical trial sponsored by...

In this interview, Dr. Stephen Marcus, CEO of Cantex Pharmaceuticals, discusses the innovative cancer therapy, Azeliragon. He explores its...

Revance Therapeutics announced two poster presentations showcasing the efficacy and performance of DAXXIFY® for the treatment of cervical dystonia....

The Synuclein-One Study has successfully detected P-SYN in cutaneous nerve fibers of patients with dementia with Lewy bodies (DLB)...